This inventor holds 1 USPTO granted patent. Top assignees: National Research Council of Canada, Oxford University Innovation Ltd, Other. Active years: 2008.
Company Filing History:
1 out of 1,039 
1 out of 483 
1 out of 834,350 Years Active: 2008
Title: The Innovations of Derek Hood
Introduction
Derek Hood is an accomplished inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His innovative work focuses on lipopolysaccharide moieties and their applications in preventing bacterial infections.
Latest Patents
Derek Hood holds 1 patent related to a lipopolysaccharide moiety. The present invention pertains to a conserved triheptosyl inner-core moiety of lipopolysaccharide that is substantially free of variable outer core oligosaccharide chain extension. This invention also includes defined mutations in the biosynthetic machinery for lipopolysaccharide (LPS) expression, which are useful for obtaining the aforementioned moiety. Furthermore, it relates to using conjugates of the LPS from the mutant strains to elicit a heterologous immune response against a wide range of disease-causing strains. More specifically, the invention addresses vaccines for the prevention of bacterial infections comprising core lipopolysaccharide.
Career Highlights
Throughout his career, Derek Hood has worked with notable institutions such as the National Research Council of Canada and Oxford University Innovation Ltd. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Derek has collaborated with esteemed colleagues, including James C Richards and Elke K H Schweda. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Derek Hood's contributions to the field of biotechnology, particularly in vaccine development, highlight his role as a significant inventor. His innovative work continues to impact the scientific community and offers promising solutions for bacterial infections.